NCT02829359View on ClinicalTrials.gov

Effects of Antiviral Therapy on HBV Reactivation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Liver Cancer
Interventions
DRUG

Entecavir therapy

Patients in the antiviral group received entecavir begin in the first 3 days before surgery for at lest 1 month.

All Listed Sponsors
lead

Guangxi Medical University

OTHER

NCT02829359 - Effects of Antiviral Therapy on HBV Reactivation | Biotech Hunter | Biotech Hunter